$ATOS Stock Due Diligence & Technical analysis

33 Просмотры

Спасибо! Поделитесь с друзьями!

Вам не понравилось видео. Спасибо за то что поделились своим мнением!

Издатель Jul 9, 2021

My previous $ATOS due diligence with technical analysis : https://youtu.be/K_I52f_5Fqg

My educational series videos for reading charts = https://www.youtube.com/playlist?list=PLEyuSzdFY88dc2AlBGCLhlSFtvj-es3rc

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; AT-H201, a drug candidate to improve lung function in COVID-19 patients; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. Atossa Therapeutics, Inc. has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the potential treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

Website : http://www.atossatherapeutics.com

Twitter : https://twitter.com/FerociousEd

Join me on my discord : https://discord.gg/47RenNKEgk

Questrade referral code: 426033354436861

Music by Youtube music library

0:00 Intro
0:18 Due Diligence
4:43 Technical Analysis

#ATOS #Atossa